Synaptogenix Statistics

Total Valuation

Synaptogenix has a market cap or net worth of $4.13 million. The enterprise value is -$17.51 million.

Market Cap	4.13M
Enterprise Value	-17.51M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Synaptogenix has 1.36 million shares outstanding. The number of shares has increased by 240.32% in one year.

Current Share Class	1.36M
Shares Outstanding	1.36M
Shares Change (YoY)	+240.32%
Shares Change (QoQ)	+9.40%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	2.54%
Float	1.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 65.36

Current Ratio	65.36
Quick Ratio	64.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.56% and return on invested capital (ROIC) is -20.35%.

Return on Equity (ROE)	-39.56%
Return on Assets (ROA)	-15.32%
Return on Capital (ROIC)	-20.35%
Revenue Per Employee	n/a
Profits Per Employee	-$1.83M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.58% in the last 52 weeks. The beta is 1.40, so Synaptogenix's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-52.58%
50-Day Moving Average	2.96
200-Day Moving Average	3.98
Relative Strength Index (RSI)	59.07
Average Volume (20 Days)	17,242

Short Selling Information

The latest short interest is 5,518, so 0.41% of the outstanding shares have been sold short.

Short Interest	5,518
Short Previous Month	5,457
Short % of Shares Out	0.41%
Short % of Float	0.42%
Short Ratio (days to cover)	0.17

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.76M
Pretax Income	-4.53M
Net Income	-9.13M
EBITDA	-6.76M
EBIT	-6.76M
Earnings Per Share (EPS)	-$8.26

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	22.07M
Total Debt	n/a
Net Cash	22.07M
Net Cash Per Share	$16.28
Equity (Book Value)	13.12M
Book Value Per Share	9.44
Working Capital	21.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.78M
Capital Expenditures	n/a
Free Cash Flow	-4.78M
FCF Per Share	-$3.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-240.32%
Shareholder Yield	-240.32%
Earnings Yield	-215.23%
FCF Yield	-112.70%

Analyst Forecast

The average price target for Synaptogenix is $14.00, which is 359.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	359.02%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2